These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33994017)

  • 21. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
    Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
    Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
    Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
    J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
    Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
    Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the addition of postoperative radiotherapy to adjuvant chemotherapy offer any benefit in patients with non-small cell lung cancer and mediastinal lymphadenopathy?
    Koulaxouzidis G; Toufektzian L; Ashrafian L; Veres L
    Interact Cardiovasc Thorac Surg; 2017 Apr; 24(4):625-630. PubMed ID: 28073986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice].
    Kepka L; Bujko K
    Pneumonol Alergol Pol; 2007; 75(3):256-61. PubMed ID: 17966101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.
    Brandt WS; Yan W; Leeman JE; Tan KS; Park BJ; Adusumilli PS; Bott MJ; Molena D; Isbell J; Chaft J; Rimner A; Jones DR
    Ann Thorac Surg; 2018 Sep; 106(3):848-855. PubMed ID: 29807005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
    Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
    Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy in early-stage non-small cell lung cancer.
    Serke M
    Front Radiat Ther Oncol; 2010; 42():135-144. PubMed ID: 19955799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.
    Billiet C; Decaluwé H; Peeters S; Vansteenkiste J; Dooms C; Haustermans K; De Leyn P; De Ruysscher D
    Radiother Oncol; 2014 Jan; 110(1):3-8. PubMed ID: 24100149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
    Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
    Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Now or later: evaluating the importance of chemotherapy timing in resectable stage III (N2) lung cancer in the National Cancer Database.
    Boffa DJ; Hancock JG; Yao X; Goldberg S; Rosen JE; Kim AW; Moreno A; Detterbeck FC
    Ann Thorac Surg; 2015 Jan; 99(1):200-8. PubMed ID: 25440272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation therapy for non-small cell lung cancer (NSCLC).
    Choy H; Chakravarthy A; Kim JS
    Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).
    Felip E; Cedrés S; Peralta S; Prat A
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix143-6. PubMed ID: 17631567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.